Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1

被引:54
作者
Paillot, R
Daly, JM
Juillard, V
Minke, JM
Hannant, D
Kydd, JH
机构
[1] Anim Hlth Trust, Ctr Prevent Med, Newmarket CB8 7UU, Suffolk, England
[2] Merial SAS, Discovery Res, F-69007 Lyon, France
[3] Merial SAS, Dept Project Management, F-69007 Lyon, France
关键词
equine IFN gamma; equine herpesvirus-1; ELISPOT assay;
D O I
10.1016/j.vaccine.2005.03.048
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Equine cytotoxic T lymphocyte (CTL) responses to equine herpesvirus-1 (EHV-1) are well characterised but little is known about the cytokine response after infection or vaccination. EHV-1 is common in horses and infects lymphocytes in vivo. This virus was used as a model to measure the synthesis of interferon gamma (IFN-gamma) by equine peripheral blood mononuclear cells (PBMC) after in vivo infection and/or in vitro stimulation with EHV-1. Both flow cytometry and ELISPOT assays were used to quantify equine IFN-gamma using a mouse anti-bovine IFN-gamma monoclonal antibody (clone CC302; shown to cross-react with recombinant equine IFN-gamma) and a rabbit anti-canine IFN-gamma polyclonal antibody. The percentage of PBMC synthesising IFN-gamma after in vitro stimulation with EHV-1 increased with age. In yearlings infected experimentally with EHV-1, PBMC showed two peaks of IFN-gamma synthesis, I I and 56 days after infection. The IFN-gamma synthesis was principally associated with CD8(+) cells. The patterns of IFN-gamma synthesis detected by intracellular IFN-gamma staining or ELISPOT were compared with CTL data and shown to be similar. These methods were also applied successfully to frozen samples of PBMC. Measurement of equine IFN-gamma using these simple techniques can now be applied to future studies on protective cellular immune responses following virus infection and/or vaccination of horses. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4541 / 4551
页数:11
相关论文
共 34 条
[1]   MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RESTRICTED CYTOTOXIC T-LYMPHOCYTE RESPONSES IN HORSES INFECTED WITH EQUINE HERPESVIRUS-1 [J].
ALLEN, G ;
YEARGAN, M ;
COSTA, LRR ;
CROSS, R .
JOURNAL OF VIROLOGY, 1995, 69 (01) :606-612
[2]  
Allen G P, 1986, Prog Vet Microbiol Immunol, V2, P78
[3]  
Allen G. P., 1999, Equine infectious diseases VIII: Proceedings of the Eighth International Conference, Dubai, 23rd-26th March 1998., P129
[4]   The physiological role of cytotoxic CD4+T-cells: the holy grail? [J].
Appay, V .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 138 (01) :10-13
[5]   Cellular responses to interferon-gamma [J].
Boehm, U ;
Klamp, T ;
Groot, M ;
Howard, JC .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :749-795
[6]   Use of recombinant modified vaccinia Ankara viral vectors for equine influenza vaccination [J].
Breathnach, CC ;
Rudersdorf, R ;
Lunn, DP .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2004, 98 (3-4) :127-136
[7]   Detection of equine arteritis virus (EAV)-specific cytotoxic CD8+ T lymphocyte precursors from EAV-infected ponies [J].
Castillo-Olivares, J ;
Tearle, JP ;
Montesso, F ;
Westcott, D ;
Kydd, JH ;
Davis-Poynter, NJ ;
Hannant, D .
JOURNAL OF GENERAL VIROLOGY, 2003, 84 :2745-2753
[8]   In vitro simulation of immunosuppression caused by Trypanosoma brucei: Active involvement of gamma interferon and tumor necrosis factor in the pathway of suppression [J].
Darji, A ;
Beschin, A ;
Sileghem, M ;
Heremans, H ;
Brys, L ;
DeBaetselier, P .
INFECTION AND IMMUNITY, 1996, 64 (06) :1937-1943
[9]   Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus [J].
Fraser, DG ;
Oaks, JL ;
Brown, WC ;
McGuire, TC .
IMMUNOLOGY, 2002, 105 (03) :295-305
[10]   CLONING AND SEQUENCING OF HORSE INTERFERON-GAMMA CDNA [J].
GRUNIG, G ;
HIMMLER, A ;
ANTCZAK, DF .
IMMUNOGENETICS, 1994, 39 (06) :448-449